
    
      BP1.4979 is a novel compound with promising efficacy on smoker which have been assessed on
      phase I studies.

      This is a multicenter,randomized, double blind, placebo controlled, phase IIb trial with
      parallel group to assess safety and efficacy of BP1.4979 in smoker.
    
  